世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い



動物成長促進剤・エンハンサ市場:製品抗菌・非抗菌毎、動物毎 - 2024年までの世界市場予測

Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2024

 

出版社 出版日電子媒体価格ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2020年1月 US$ 5,650
シングルユーザライセンス
161p140点

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の動物成長促進剤・エンハンサ市場に関する調査レポートです。

“The animal growth promoters and performance enhancers market projected to grow at a CAGR of 5.9% during the forecast period (2019-2024).”

The global animal growth promoters and performance enhancers market is projected to reach USD 18.5 billion by 2024 from an estimated USD 13.9 billion in 2019, at a CAGR of 5.9% during the forecast period. The key factors driving the growth of this market is the increasing global meat demand, research into alternatives to antibiotics, and the need to deal with epidemics and environmental factors. However, various countries have stringent regulations in place against antibiotics and particular growth promoters, which has affected their adoption.

“By type, the non-antibiotic growth promoters segment is expected to grow at the highest CAGR during the forecast period (2019-2024).”

On the basis of type, the market is segmented into antibiotic and non-antibiotic growth promoters. The non-antibiotic growth promoters segment commanded the largest share of the animal growth promoters and performance enhancers market in 2018. This large share of this segment is due to the economic benefits, a wide range of substances (acidifiers, prebiotics & probiotics, feed enzymes, phytogenic, hormones and others growth promoters), numerous applications in various production animals, greater sustainability, and the increasing number of regulations on antibiotics.

“By animal type, the poultry segment is expected to dominate the market during the forecast period (2019-2024).”

Based on animal type, the market is segmented into poultry, porcine, livestock, aquaculture, and other animals (equine, rabbit, camel, deer, yak, and geese). The poultry segment marked the largest share of the animal growth promoters and performance enhancers market in 2018. The large market share of this segment can be attributed to the increasing demand for poultry meat & eggs, novel diet approaches, and antibiotics phase-outs, resulting in the development of alternatives.

“The Europe region to witness the highest growth during the forecast period (2019-2024).”

The Europe market is projected to register the highest growth during the forecast period. Factors such as rising in domestic livestock, poultry and pork production, and decreasing meat imports owing to the ban of certain growth promoters in Europe are driving the growth for the animal growth promoters and performance enhancers market in Europe. Other factors also include technological advancements in animal production in this region and increasing meat production.

A breakdown of the primary participants referred to for this report is provided below:

- By Company Type: Tier 1-21%, Tier 2-26%, and Tier 3-53%
- By Designation: C-level-32%, Director-level-23%, and Others-45%
- By Region: North America-36%, Europe-32%, Asia Pacific-17%, RoW-15%

Prominent players in the global animal growth promoters and performance enhancers  market include are Merck and Co. Inc. (US), Cargill Inc. (US), Royal DSM N. V. (Germany), Bupo Animal Health (SA), Elanco Animal Health Inc. (US), CHR Hansen (UK), Alltech Inc. (US), Phibro Animal Health Corporation (US), Kemin Industries (US), and SHV (Nutreco) (UK).

Research Coverage:

The report analyzes the animal growth promoters and performance enhancers market and aims at estimating the market size and future growth potential of this market based on various segments such as product, animal type, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of the top players in the animal growth promoters and performance enhancers market. The report analyzes the market based on the product, animal type, and region.
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the animal growth promoters and performance enhancers market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various animal growth promoters and performance enhancers equipment across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the animal growth promoters and performance enhancers market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the animal growth promoters and performance enhancers market.



目次

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.4 YEARS CONSIDERED FOR THE STUDY 18
1.5 CURRENCY 19
1.6 LIMITATIONS 19
1.7 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 23
2.2 MARKET SIZE ESTIMATION 24
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 25
2.3 DATA TRIANGULATION 26
2.4 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 31
4.1 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET OVERVIEW 31
4.2 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE (2018) 32
4.3 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS
AND PERFORMANCE ENHANCERS MARKET 33
5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.2 MARKET DYNAMICS 34
5.2.1 DRIVERS 35
5.2.1.1 Continuous growth in the global meat demand 35
5.2.1.2 Research into alternatives to antibiotics and hormones and increasing demand for non-antibiotic growth promoters 36
5.2.1.3 Rise in animal epidemics and climate changes 37
-
5.2.2 RESTRAINTS 37
5.2.2.1 Stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals 37
5.2.3 OPPORTUNITIES 39
5.2.3.1 Focus on increasing environment sustainability 39
5.2.4 CHALLENGES 40
5.2.4.1 Increasing global feed tonnage and high feed costs leading to the adoption of conventional feeding systems 40
6 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE 41
6.1 INTRODUCTION 42
6.2 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS 42
6.2.1 PREBIOTICS & PROBIOTICS 44
6.2.1.1 Prebiotics & probiotics hold the largest share of the market 44
6.2.2 ACIDIFIERS 47
6.2.2.1 Regulations on antibiotics and wide applications in different production animals have driven the use of acidifiers 47
6.2.3 PHYTOGENICS 49
6.2.3.1 Natural performance enhancement and antioxidative & disease defense properties have supported the use of phytogenics 49
6.2.4 FEED ENZYMES 51
6.2.4.1 Feed enzymes segment is expected to benefit greatly from the bans of antibiotics and hormones 51
6.2.5 HORMONES 53
6.2.5.1 Human health implications and restricted usage due to regulations will hamper the growth of the hormones segment 53
6.2.6 OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS 56
6.3 ANTIBIOTIC GROWTH PROMOTERS 58
6.3.1 ANTIBIOTICS TO FACE A GRADUAL DECLINE DUE TO UNFAVORABLE REGULATIONS AND BANS ON THEIR USE 58
7 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE 62
7.1 INTRODUCTION 63
7.2 POULTRY 63
7.2.1 IN 2018, THE POULTRY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET 63
7.3 SWINE 65
7.3.1 RISING DEMAND FOR PORK MEAT AND INCREASING AWARENESS OF AFRICAN SWINE FEVER (ASF) OUTBREAKS TO DRIVE THE ADOPTION OF GROWTH PROMOTERS AND PERFORMANCE ENHANCERS 65
-
7.4 LIVESTOCK 66
7.4.1 THE LIVESTOCK SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 66
7.5 AQUATIC ANIMALS 67
7.5.1 GROWING PRODUCTION AND CONSUMPTION OF SEAFOOD TO DRIVE THE DEMAND FOR GROWTH PROMOTERS FOR AQUATIC ANIMALS 67
7.6 OTHER ANIMALS 68
8 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION 69
8.1 INTRODUCTION 70
8.2 ASIA PACIFIC 71
8.2.1 CHINA 73
8.2.1.1 China dominates the APAC animal growth promoters and performance enhancers market 73
8.2.2 INDIA 75
8.2.2.1 Large livestock population and increasing production and export capacities to drive market growth in the country 75
8.2.3 JAPAN 77
8.2.3.1 Rising domestic meat demand and government efforts to encourage animal producers are driving the demand for promoters in Japan 77
8.2.4 AUSTRALIA 78
8.2.4.1 Large cattle population and heavy meat exports have supported the market in Australia 78
8.2.5 REST OF ASIA PACIFIC 79
8.2.5.1 Lack of a defined regulatory scenario has resulted in the wide use of antibiotic growth promoters in the RoAPAC 79
8.3 NORTH AMERICA 81
8.3.1 US 82
8.3.1.1 US holds the largest share of the North American market 82
8.3.2 CANADA 84
8.3.2.1 Canada is a prominent meat and aquaculture producer and exporter 84
8.4 EUROPE 87
8.4.1 RUSSIA 89
8.4.1.1 Russia holds the largest share of the European market 89
8.4.2 REST OF EUROPE 91
8.4.2.1 Technological advancements and the strong trade industry have supported the RoE market 91
8.5 REST OF THE WORLD 93
8.5.1 BRAZIL 94
8.5.1.1 Brazil dominates the RoW market for animal growth promoters and performance enhancers 94
8.5.2 REST OF LATIN AMERICA 95
8.5.2.1 Strong demand for animal products and supportive initiatives have supported the market in the RoLA 95
8.5.3 MIDDLE EAST 97
8.5.3.1 Increasing demand for chicken and seafood have contributed to market growth in the Middle East 97
8.5.4 AFRICA 98
8.5.4.1 Reliance on conventional livestock production practices may hamper the market growth in Africa 98
9 COMPETITIVE LANDSCAPE 100
9.1 INTRODUCTION 100
9.2 MARKET SHARE ANALYSIS 100
9.3 COMPETITIVE LEADERSHIP MAPPING (2018) 102
9.3.1 VISIONARY LEADERS 102
9.3.2 INNOVATORS 102
9.3.3 DYNAMIC DIFFERENTIATORS 102
9.3.4 EMERGING COMPANIES 102
9.4 COMPETITIVE SCENARIO 104
9.4.1 KEY DEVELOPMENTS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET 104
9.4.2 KEY PRODUCT LAUNCHES 105
9.4.3 KEY ACQUISITIONS 106
9.4.4 KEY EXPANSIONS 106
10 COMPANY PROFILES 107
(Business overview, Products offered, Recent developments & Competitive Analysis)*
10.1 CARGILL, INC. 107
10.2 ROYAL DSM N.V. 111
10.3 ELANCO ANIMAL HEALTH INC. 115
10.4 MERCK & CO., INC. 118
10.5 ALLTECH, INC. 120
10.6 ARCHER-DANIELS-MIDLAND COMPANY (ADM) 122
10.7 VETOQUINOL 127
10.8 BUPO ANIMAL HEALTH 129
10.9 CHR. HANSEN 131
10.10 NOVUS INTERNATIONAL, INC. 133
10.11 ASSOCIATED BRITISH FOODS PLC 136
10.12 ERBER AG 138
10.13 PHIBRO ANIMAL HEALTH CORPORATION 141
10.14 KEMIN INDUSTRIES 144
10.15 NUTRECO (A WHOLLY OWNED SUBSIDIARY OF SHV GROUP) 147
10.16 BASF SE 150
-
10.17 LALLEMAND INC. 150
10.18 BLUESTAR ADISSEO COMPANY 151
10.19 EVONIK INDUSTRIES AG 151
10.20 LAND O’LAKES, INC. 152
*Details on Business overview, Products offered, Recent developments & Competitive Analysis might not be captured in case of unlisted companies.
11 APPENDIX 153
11.1 DISCUSSION GUIDE 153
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 157
11.3 AVAILABLE CUSTOMIZATIONS 159
11.4 RELATED REPORTS 159
11.5 AUTHOR DETAILS 160

 

LIST OF TABLES

TABLE 1 PER CAPITA MEAT CONSUMPTION OF LIVESTOCK PRODUCTS 35
TABLE 2 BANS ON ANTIBIOTICS AND HORMONES, BY COUNTRY AND YEAR 38
TABLE 3 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
BY TYPE, 2017-2024 (USD MILLION) 42
TABLE 4 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 42
TABLE 5 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION) 43
TABLE 6 NORTH AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 43
TABLE 7 EUROPE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 43
TABLE 8 APAC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 44
TABLE 9 ROW: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 44
TABLE 10 PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION) 45
TABLE 11 NORTH AMERICA: PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 45
TABLE 12 EUROPE: PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 46
TABLE 13 APAC: PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 46
TABLE 14 ROW: PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 46
TABLE 15 ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
BY REGION, 2017-2024 (USD MILLION) 47
TABLE 16 NORTH AMERICA: ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 48
TABLE 17 EUROPE: ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 48
TABLE 18 APAC: ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 48
TABLE 19 ROW: ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 49
TABLE 20 PHYTOGENIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION) 50
TABLE 21 NORTH AMERICA: PHYTOGENIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 50
TABLE 22 EUROPE: PHYTOGENIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 50
TABLE 23 APAC: PHYTOGENIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 51
TABLE 24 ROW: PHYTOGENIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 51
TABLE 25 FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION) 52
TABLE 26 NORTH AMERICA: FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 52
TABLE 27 EUROPE: FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 52
TABLE 28 APAC: FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 53
TABLE 29 ROW: FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 53
TABLE 30 HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
BY REGION, 2017-2024 (USD MILLION) 54
TABLE 31 NORTH AMERICA: HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 55
TABLE 32 EUROPE: HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 55
TABLE 33 APAC: HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 55
TABLE 34 ROW: HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 56
TABLE 35 OTHER NON-ANTIBIOTIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS, BY REGION, 2017-2024 (USD MILLION) 57
TABLE 36 NORTH AMERICA: OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 57
TABLE 37 EUROPE: OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 57
TABLE 38 APAC: OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 58
TABLE 39 ROW: OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 58
TABLE 40 PERCENTAGE SALES OF ANTIMICROBIAL SUBSTANCES IN THE US, 2017 59
TABLE 41 ANTIBIOTICS BANS & REGULATIONS, BY COUNTRY 59
TABLE 42 ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
BY REGION, 2017-2024 (USD MILLION) 60
TABLE 43 NORTH AMERICA: ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 60
TABLE 44 EUROPE: ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 60
TABLE 45 APAC: ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 61
TABLE 46 ROW: ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 61
TABLE 47 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
BY ANIMAL TYPE, 2017-2024 (USD MILLION) 63
TABLE 48 WORLD’S TOP 15 COUNTRIES THAT EXPORTED FRESH OR CHILLED CHICKEN DURING 2018 64
TABLE 49 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
FOR POULTRY, BY REGION, 2017-2024 (USD MILLION) 65
TABLE 50 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
FOR SWINE, BY REGION, 2017-2024 (USD MILLION) 66
TABLE 51 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
FOR LIVESTOCK, BY REGION, 2017-2024 (USD MILLION) 67
TABLE 52 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
FOR AQUATIC ANIMALS, BY REGION, 2017-2024 (USD MILLION) 68
TABLE 53 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
FOR OTHER ANIMALS, BY REGION, 2017-2024 (USD MILLION) 68
TABLE 54 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
BY REGION, 2017-2024 (USD MILLION) 70
TABLE 55 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 72
TABLE 56 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 72
TABLE 57 ASIA PACIFIC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 72
TABLE 58 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 73
TABLE 59 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 74
TABLE 60 CHINA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 74
TABLE 61 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 75
TABLE 62 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 76
TABLE 63 INDIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 76
TABLE 64 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 76
TABLE 65 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 77
TABLE 66 JAPAN: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 77
TABLE 67 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 78
TABLE 68 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 78
TABLE 69 AUSTRALIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 79
TABLE 70 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 79
TABLE 71 REGULATORY SCENARIO FOR ANTIBIOTICS IN THE ROAPAC, BY COUNTRY 80
TABLE 72 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 80
TABLE 73 ROAPAC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 80
TABLE 74 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 81
TABLE 75 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 81
TABLE 76 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 81
TABLE 77 NORTH AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 82
TABLE 78 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 82
TABLE 79 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
BY TYPE, 2017-2024 (USD MILLION) 83
TABLE 80 US: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 83
TABLE 81 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
BY ANIMAL TYPE, 2017-2024 (USD MILLION) 84
TABLE 82 BEEF AND VEAL EXPORTS BY CANADA BETWEEN OCTOBER 2018
AND OCTOBER 2019 85
TABLE 83 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 85
TABLE 84 CANADA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 86
TABLE 85 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 86
TABLE 86 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 88
TABLE 87 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 88
TABLE 88 EUROPE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 88
TABLE 89 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 89
TABLE 90 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 90
TABLE 91 RUSSIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 90
TABLE 92 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 90
TABLE 93 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 91
TABLE 94 ROE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 92
TABLE 95 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 92
TABLE 96 ROW: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 93
TABLE 97 ROW: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 93
TABLE 98 ROW: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 93
TABLE 99 ROW: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 94
TABLE 100 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 94
TABLE 101 BRAZIL: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 95
TABLE 102 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 95
TABLE 103 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 96
TABLE 104 ROLA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 96
TABLE 105 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 97
TABLE 106 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 97
TABLE 107 MIDDLE EAST: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 98
TABLE 108 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 98
TABLE 109 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 99
TABLE 110 AFRICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION) 99
TABLE 111 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION) 99
TABLE 112 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2016-2019) 104
TABLE 113 PRODUCT LAUNCHES (2016-2019) 105
TABLE 114 ACQUISITIONS (2016-2019) 106
TABLE 115 EXPANSIONS (2016-2019) 106

 

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 20
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 23
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 24
FIGURE 4 MARKET SIZE ESTIMATION: ANIMAL GROWTH PROMOTERS
AND PERFORMANCE ENHANCERS MARKET 25
FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY 26
FIGURE 6 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
BY TYPE, 2019 VS. 2024 (USD BILLION) 28
FIGURE 7 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019 VS. 2024 (USD BILLION) 29
FIGURE 8 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET,
BY ANIMAL TYPE, 2019 VS. 2024 (USD BILLION) 29
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS
AND PERFORMANCE ENHANCERS MARKET 30
FIGURE 10 CONTINUOUS GROWTH IN THE GLOBAL MEAT DEMAND TO DRIVE
MARKET GROWTH 31
FIGURE 11 NON-ANTIBIOTIC GROWTH PROMOTERS ACCOUNTED FOR THE LARGEST SHARE
OF THE APAC MARKET IN 2018 32
FIGURE 12 EUROPE TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD 33
FIGURE 13 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 34
FIGURE 14 ASIA PACIFIC WILL DOMINATE THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET DURING THE FORECAST PERIOD 70
FIGURE 15 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT 71
FIGURE 16 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT 87
FIGURE 17 VALUE-BASED MARKET SHARES OF KEY PLAYERS, 2018 100
FIGURE 18 COMPETITIVE LEADERSHIP MAPPING: ANIMAL GROWTH PROMOTERS
AND PERFORMANCE ENHANCERS MARKET 103
FIGURE 19 ROYAL DSM N.V.: COMPANY SNAPSHOT 111
FIGURE 20 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT 115
FIGURE 21 MERCK & CO. INC.: COMPANY SNAPSHOT 118
FIGURE 22 ARCHER-DANIELS-MIDLAND COMPANY: COMPANY SNAPSHOT 122
FIGURE 23 CHR. HANSEN: COMPANY SNAPSHOT 131
FIGURE 24 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 136
FIGURE 25 PHIBRO ANIMAL HEALTH CORPORATION: COMPANY SNAPSHOT 141

 

COPYRIGHT(C) 2011-2020 DATA RESOURCES, Inc. ALL RIGHTS RESERVED.